Myelodysplastic syndrome, unspecified Short description: Myelodysplastic synd NOS. ICD-9-CM 238.75 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 238.75 should only be used for claims with a date of service on or before September 30, 2015.
Myelodysplastic syndrome, unspecified 2015 Billable Thru Sept 30/2015 Non-Billable On/After Oct 1/2015 ICD-9-CM 238.75 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 238.75 should only be used for claims with a date of service on or before September 30, 2015.
Billable Medical Code for Myelodysplastic Syndrome, Unspecified Diagnosis Code for Reimbursement Claim: ICD-9-CM 238.75. Code will be replaced by October 2015 and relabeled as ICD-10-CM 238.75. The Short Description Is: Myelodysplastic synd NOS. Known As
Low grade myelodysplastic syndrome lesions 2015 Billable Thru Sept 30/2015 Non-Billable On/After Oct 1/2015 ICD-9-CM 238.72 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 238.72 should only be used for claims with a date of service on or before September 30, 2015.
Myelodysplastic syndrome (clinical) Clinical Information. (mye-eh-lo-dis-plas-tik sin-drome) disease in which the bone marrow does not function normally. A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into acute myeloid leukemia.
Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants. nih national cancer institute.
myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants. nih national cancer institute. Codes.
(who, 2001) A disorder characterized by insufficiently healthy hematapoietic cell production by the bone marrow. A group of diseases in which the bone marrow does not make enough healthy blood cells.
Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. If you have a myelodysplastic syndrome, the stem cells do not mature into healthy blood cells. This leaves less room for healthy cells, which can lead to infection, anemia, or easy bleeding.myelodysplastic syndromes often do not cause early symptoms and are sometimes found during a routine blood test. If you have symptoms, they may include#N#shortness of breath#N#weakness or feeling tired#N#skin that is paler than usual#N#easy bruising or bleeding#N#pinpoint spots under the skin caused by bleeding#N#fever or frequent infections#N#myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants. nih national cancer institute 1 shortness of breath 2 weakness or feeling tired 3 skin that is paler than usual 4 easy bruising or bleeding 5 pinpoint spots under the skin caused by bleeding 6 fever or frequent infections
The myelodysplastic syndromes (also known as MDS or myelodysplasia) are hematological (i.e., blood-related) medical conditions with ineffective production (or "dysplasia") of all blood cells.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D46.9. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code D46.9 and a single ICD9 code, 238.75 is an approximate match for comparison and conversion purposes.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.